{"schema_version":"secwatch.filing_event.v1","accession":"0001753926-24-001473","form_type":"8-K","ticker":"LIPO","cik":"0001347242","company_name":"LIPELLA PHARMACEUTICALS INC.","filed_at":"2024-08-23T23:59:59+00:00","discovered_at":"2026-05-14T18:03:12.746238+00:00","generated_at":"2026-05-31T07:48:49.991360+00:00","sec_items":["3.01"],"event_type":"regulatory","sentiment":"negative","materiality_score":0.7,"calibrated_materiality_score":0.7,"confidence":"high","headline":"Lipella receives Nasdaq delisting notice; equity $1.7M vs $2.5M minimum","bullets":["Nasdaq notified Lipella on Aug 21, 2024 of non-compliance with $2.5M minimum stockholders' equity requirement.","Company reported stockholders' equity of $1,703,798 in Q2 10-Q, below the $2.5M threshold.","Company must submit compliance plan by Oct 7, 2024; intends to do so.","If plan accepted, Nasdaq may grant up to 180-day extension from Aug 21, 2024.","Failure to regain compliance could result in delisting of LIPO common stock."],"urls":{"canonical":"https://secwatch.observer/filing/0001753926-24-001473","json":"https://secwatch.observer/filing/0001753926-24-001473.json","markdown":"https://secwatch.observer/filing/0001753926-24-001473.md","text":"https://secwatch.observer/filing/0001753926-24-001473.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1347242/000175392624001473/0001753926-24-001473-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1347242/000175392624001473/g084405_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-31T07:48:49.991360+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}